Xencor XNCR
NASDAQ XNCR
$26.61 -0.01 (-0.04%)
As of: Sep 4, 2026 · 3:59 PM EDT

Xencor (XNCR) Accumulated Expenses (2013 - 2026)

Xencor (XNCR) posted quarterly Accumulated Expenses of $34.3 million for Q1 2026, up 113.24% year-over-year from $16.1 million in Q1 2025, and down 2.02% quarter-over-quarter from $35.0 million in Q4 2025.

Analysis

Xencor (XNCR) Accumulated Expenses (2013 - 2026) Analysis & Trends

Xencor (XNCR) has reported Accumulated Expenses for 14 consecutive years, with $34.3 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Accumulated Expenses rose 113.24% year-over-year to $34.3 million; the TTM figure through Mar 2026 stood at $34.3 million (up 113.24% YoY), while the FY2025 annual figure was $35.0 million, up 81.92% from the prior year.
  • Accumulated Expenses retreated to $34.3 million in Q1 2026 per XNCR's latest filing, from $35.0 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $35.0 million in Q4 2025 and bottomed at $12.6 million in Q1 2022.
  • Historically, Accumulated Expenses has averaged $21.4 million across 5 years, with a median of $19.3 million in 2022.
  • Annual changes were most pronounced in 2024 — Accumulated Expenses dropped 18.45% — and 2026, when it jumped 113.24%.
  • Xencor's Accumulated Expenses stood at $18.7 million in 2022, then advanced by 25.82% to $23.6 million in 2023, then fell by 18.45% to $19.2 million in 2024, then jumped by 81.92% to $35.0 million in 2025, then declined by 2.02% to $34.3 million in 2026.
  • Business Quant data shows XNCR's Accumulated Expenses at $34.3 million in Q1 2026, $35.0 million in Q4 2025, and $28.1 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Xencor 2.02 Bn 1.65 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 36.45 Mn
Mar 31, 2026 34.25 Mn
Dec 31, 2025 34.96 Mn
Sep 30, 2025 28.11 Mn
Jun 30, 2025 23.88 Mn
Mar 31, 2025 16.06 Mn
Dec 31, 2024 19.22 Mn
Sep 30, 2024 25.41 Mn
Jun 30, 2024 19.56 Mn
Mar 31, 2024 13.49 Mn
Dec 31, 2023 23.56 Mn
Sep 30, 2023 24.47 Mn
Jun 30, 2023 18.44 Mn
Mar 31, 2023 15.14 Mn
Dec 31, 2022 18.73 Mn
Sep 30, 2022 19.29 Mn
Jun 30, 2022 16.35 Mn
Mar 31, 2022 12.61 Mn
Dec 31, 2021 19.44 Mn
Sep 30, 2021 22.11 Mn